Matches in Wikidata for { <http://www.wikidata.org/entity/Q60230376> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q60230376 description "article scientifique publié en 2011" @default.
- Q60230376 description "im April 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60230376 description "wetenschappelijk artikel" @default.
- Q60230376 description "наукова стаття, опублікована у квітні 2011" @default.
- Q60230376 name "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 name "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 type Item @default.
- Q60230376 label "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 label "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 prefLabel "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 prefLabel "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 P1433 Q60230376-754B9094-812D-417C-98AE-9C060D878C25 @default.
- Q60230376 P1476 Q60230376-ABD201D9-264B-4F51-85DB-80181AF33921 @default.
- Q60230376 P2093 Q60230376-0DAA1BFF-92C0-43FB-AB42-22C5CBDBC914 @default.
- Q60230376 P2093 Q60230376-247EB690-19A5-413B-9CA8-E6FB0E04D138 @default.
- Q60230376 P2093 Q60230376-3D2403A7-EECE-4F71-8E10-FAAB070B0B9D @default.
- Q60230376 P2093 Q60230376-4757934E-C023-4EB7-BAB4-40A607FCB33B @default.
- Q60230376 P2093 Q60230376-572C88F7-ADC6-456F-93A4-DDC0A6276328 @default.
- Q60230376 P2093 Q60230376-9FBA00F9-2A33-4761-AE6F-8FBBD7006B40 @default.
- Q60230376 P304 Q60230376-45339C3F-BF1B-4EB8-9286-751E8AD22E4C @default.
- Q60230376 P31 Q60230376-C48393E2-17C3-474E-A23B-E94F774CFC78 @default.
- Q60230376 P356 Q60230376-3C93F608-B383-43A9-83A4-24C92E5C469D @default.
- Q60230376 P407 Q60230376-635CC3E6-BD85-4CD4-980A-C965DFB0EDDF @default.
- Q60230376 P433 Q60230376-FAF40A7B-9B55-4964-9FD4-E136439A5905 @default.
- Q60230376 P478 Q60230376-52A08A0B-F115-4073-BADB-9F94DAEB89C7 @default.
- Q60230376 P50 Q60230376-BA0B5673-0CAE-42D9-9262-23B85A7A1909 @default.
- Q60230376 P577 Q60230376-C871E50D-D73E-46BC-918E-51ED695EF197 @default.
- Q60230376 P921 Q60230376-BA982950-A483-485B-9A8A-1101A9C5B38C @default.
- Q60230376 P356 1538-7445.AM2011-3541 @default.
- Q60230376 P1433 Q326097 @default.
- Q60230376 P1476 "Abstract 3541: Combination of the ruthenium compound KP1339 with the tyrosine kinase inhibitor sorafenib: A promising approach for the treatment of human hepatoma" @default.
- Q60230376 P2093 "Bernhard K. Keppler" @default.
- Q60230376 P2093 "Bihter Atil" @default.
- Q60230376 P2093 "Elisabeth Gal" @default.
- Q60230376 P2093 "Kushtrim Kryeziu" @default.
- Q60230376 P2093 "Ute Jungwirth" @default.
- Q60230376 P2093 "Walter Berger" @default.
- Q60230376 P304 "3541-3541" @default.
- Q60230376 P31 Q13442814 @default.
- Q60230376 P356 "10.1158/1538-7445.AM2011-3541" @default.
- Q60230376 P407 Q1860 @default.
- Q60230376 P433 "8 Supplement" @default.
- Q60230376 P478 "71" @default.
- Q60230376 P50 Q42173445 @default.
- Q60230376 P577 "2011-04-15T00:00:00Z" @default.
- Q60230376 P921 Q1148337 @default.